v3.25.1
Earnings/loss (-) per share
12 Months Ended
Dec. 31, 2024
Income/loss (-) per share  
Income/loss (-) per share

12. Earnings/loss (-) per share

Year ended December 31,

    

2024

    

2023

    

2022

Net profit/loss (-) attributable to owners of the parent (Euro, in thousands)

74,082

211,697

(217,991)

Number of shares (thousands)

Weighted average number of shares for the purpose of basic earnings/loss (-) per share

65,897

65,884

65,699

Basic earnings/loss (-) per share (Euros)

1.12

3.21

(3.32)

Net profit/loss (-) attributable to owners of the parent (Euro, in thousands)

74,082

211,697

(217,991)

Number of shares (thousands)

Weighted average number of shares for the purpose of diluted earnings/loss (-) per share

65,897

65,884

65,699

Number of dilutive potential ordinary shares

45

49

Diluted earnings/loss (-) per share (Euros)

1.12

3.21

(3.32)

As our operations reported a net loss in 2022, the outstanding subscription rights (specified in note 32) have an anti-dilutive effect rather than a dilutive effect. Consequently, basic and diluted loss per share were the same for 2022.

Reference is also made to note 2 where an explanation is provided about the terms and conditions of the outstanding subsequent Warrant B that can, potentially, be exercised by Gilead and lead to a dilutive effect. Due to the exercise price mechanism of the Gilead Warrant B, this warrant was out-of-the-money for all years presented.